MTOR and metabolic syndrome: Based on an earlier RCT on proteins and insoluble fibre in participants with Metabolic Syndrome (“ProFiMet”), the role of the intestinal absorption of branched-chain-amino acids—potent activators of the mTOR pathway—was discussed [32] In OptiFiT, faecal samples were not collected.